| Device |
transdermal test for assessment of glomerular filtration rate |
| Definition |
A test used to assess a patient’s glomerular filtration rate (GFR) by injecting a fluorescent tracer molecule into the blood stream and measuring the amount of fluorescence through the skin with a transdermal sensor. |
| Physical State |
The test system may include sensors, software, a monitor, and a molecular tracer agent which is injected into the patient. |
| Technical Method |
A tracer is injected into a patient’s blood stream and a sensor is used to measure the tracer signal from the blood through the patient’s skin. This signal is converted to a glomerular filtration rate. |
| Target Area |
Kidney or Renal |
| Review Panel |
Gastroenterology/Urology |
| Product Code | SDK |
| Premarket Review |
Renal, Gastrointestinal, Obesity and Transplant Devices
(DHT3A)
Renal, Gastrointestinal, Obesity and Transplant Devices
(DHT3A)
|
| Submission Type |
PMA
|
| Device Class |
3
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
| Third Party Review |
Not Third Party Eligible |